CONTINUE TO SITE
OR WAIT null SECS
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
A Welcome Addition to the Child and Adolescent ADHD Armamentarium
This new medication is a huge leap forward for treating attention-deficit/hyperactivity disorder.
Ann Childress, MD, talks about Qelbree and the importance of its approval by the US Food and Drug Administration.
Dr Childress is a practicing psychiatrist with a subspecialty in child and adolescent psychiatry, clinical researcher, and president of the Center for Psychiatry and Behavioral Medicine, Inc. in Las Vegas.